CompletedPhase 4ketamine

A Comparison of Proprietary Formulations of Oral Ketamine + Aspirin and Oral Ketamine Alone for Musculoskeletal Pain

Sponsored by Antonios Likourezos

NCT ID
NCT04860804
Target Enrollment
60 participants
Start Date
2021-04-22
Est. Completion
2021-12-31

About This Study

Acute Pain is one of the most frequent chief complaints and the main reason for visiting the Emergency Department (ED). The acute pain in the ED is largely prevalent across the country with recent literature demonstrating that 61-91% of patients are admitted to the ED due to a variety of acute painful syndromes. There is a lack of good options for pain control in such settings.

Conditions Studied

Pain

Interventions

  • Aspirin and Ketamine
  • Oral Ketamine

Eligibility

Age:18 Years - 120 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Patients age 18 and older
* acute musculoskeletal pain
* initial pain score of 5 or more on a standard 11- point (0 to 10) numeric rating scale.
* awake, alert, and oriented to person, place, and time

Exclusion Criteria:

* altered mental status,
* allergy to aspirin and ketamine,
* pregnant
* unstable vital signs (systolic blood pressure \<90 or\>180 mm Hg, pulse rate \<50 or \>150 beats/ min, and respiration rate \<10 or \>30 breaths/min)
* inability to provide consent
* consumption of Aspirin or NSAID's within 6 hours of arrival to the ED
* active PUD
* history of GI Hemorrhage
* history of renal and hepatic insufficiency
* past medical history of alcohol or drug abuse
* schizophrenia

Study Locations (1)

Maimonides Medical Center
Brooklyn, New York, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source